この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2002/5/101 分で読めます
Pediculicide Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is proposing to amend the final monograph for over-the-counter (OTC) pediculicide drug products to revise labeling for the statement of identity, warnings, directions, and other required statements. Pediculicide drug products are used for the treatment of head, pubic (crab), and body lice. This proposal is part of FDA's ongoing review of OTC drug products.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →